Medbox to be Featured on CNBC's "Closing Bell"
Medbox to be Featured on CNBC's "Closing Bell"
Company CEO to be interviewed live regarding the booming marijuana industry
WEST HOLLYWOOD, Calif., Jan. 6, 2014 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing industry specific consulting services and patented systems to the medical and retail industries, announced that it has been scheduled to appear on CNBC's popular television show, "Closing Bell."
"We are thrilled that we have been invited back to "Closing Bell" and updating our company's performance since our initial appearance in December of 2012. We look forward to discussing our company's success in the marijuana sector as well as examining the newly established recreational markets of Colorado and Washington," stated Bruce Bedrick CEO of Medbox, Inc.
The live interview is scheduled to air January 6, 2014 at 4:45 EST / 1:45 PST on CNBC.
About Medbox, Inc:
Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Florida, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.
Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the company offers an industry award winning medical vaporizer product.
Medbox, Inc. is a publicly traded company, and is quoted on the OTC Markets, ticker symbol MDBX.
For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medboxinc.com.
SOURCE Medbox, Inc.
Medbox, Inc.
Web Site: http://www.medboxinc.com
-------
Profile: intent
0 Comments:
Post a Comment
<< Home